This supplemental report is being submitted to provide the investigation conclusion.Testing was performed at abbott diagnostics scarborough, inc.On retained kit lot 153829 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing records and quality control release testing was reviewed for test kit part number 7d2648 / lot 153829 and test base part number 10732998 / lot 152121.The lot met the required release specifications.A review of the complaints reported as false positive patient results (confirmed and unconfirmed, conflicting results) related to kit lot 153829 showed that the complaint rate is (b)(4).In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issue, however it could be attributed to the specific patient sample.The sample may have contained specific substances which may have affected the results.
|